THE
3004.90.35

Tariff line in 3004.90 — Other types

Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs:…

$69MIndia’s exports in FY 2025-26
99countries bought from India
+9%against FY 2024-25 ($63M)
2,140tonnes shipped in FY 2025-26

India’s exports, year by year

US$, Indian financial years (April–March). Source: DGCI&S, Ministry of Commerce (Tradestat).

Biggest buyers, FY 2025-26

  1. United States
  2. South Africa
  3. Canada
  4. Australia
  5. Latvia
  6. Uzbekistan
  7. Colombia
  8. Mexico
  9. United Kingdom
  10. Chile

Ranked by value. Country-by-country figures are not shown.

GST on this code

5%

  • 5% — Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, including Ayurvedic, Unani, homoeopathic siddha or Bio-chemic systems medicaments, put up for retail saleNotification 9/2025-CT(R), Schedule I, entry 234

GST on supply within India, as of 1 May 2026. Exports are zero-rated supplies.

Other codes in 3004.90

3004.90.99Medicaments — other types$11B in FY 2025-263004.90.49Anticancer drugs: other$992M in FY 2025-263004.90.79Antihepertensive drugs: other$947M in FY 2025-263004.90.69Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: Other$907M in FY 2025-263004.90.39Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs:…$659M in FY 2025-263004.90.81Medicaments — other: phenobarbitone, memphobarbitone, primidone, phenytoin, carbamazepine, ethosuximide, valporic acid…$318M in FY 2025-263004.90.82Medicaments — other: other antiepileptic drugs$312M in FY 2025-263004.90.29Anthelmintics drugs; Antiamoebic and other Antiprotozal drugs; Antifungal drugs: Other$304M in FY 2025-263004.90.63Nonsteroidal antiinflammatory, analgesics and antipyratic drugs: Ibuprofen with or without paracetamol or…$289M in FY 2025-263004.90.57Antitubercular drugs; Antileprotic drugs; Antimalarial drugs: Other Antitubercular drugs$259M in FY 2025-263004.90.34Antihistaminics drugs; Antacids preparations; Antiulcer drugs; Antiemitics and other Gastrointestinal drugs:…$245M in FY 2025-263004.90.11Medicaments — other, ayurvedic, Unani, Homoeopathic, Siddha or Bio- chemic systems medicaments, put up for retail sale: Of…$176M in FY 2025-26